上海科华生物工程股份有限公司 关于产品获得医疗器械注册证的公告

Group 1 - The company has received a medical device registration certificate for in vitro diagnostic reagents from the Shanghai Municipal Drug Administration [1] - The acquisition of this new product registration enriches the company's product line and is expected to have a positive impact on business development [1] - The company is currently unable to predict the future revenue impact of the new products and advises investors to pay attention to investment risks [1]